National Medical Products Administration

China's drug industry is pivoting to AI-powered drug candidates to drive a new wave of deals, with 81 deals sealed in the first half of the year, nearly matching 80% of last year's total. China now ac…

China's clinical drug trials hit a record 5,215 in 2025, more than double the 2020 figure, with 57.5% for new drugs, as Beijing's push to make biotech a strategic industry raises US security concerns.…

China's National Medical Products Administration issued new guidelines Monday tightening rules on online prescription drug sales, requiring real-name authentication and prohibiting AI from reviewing o…